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Discontinuing Antiepileptic Drugs after Pediatric 
Epilepsy Surgery for Focal Cortical Dysplasia
Purpose: Antiepileptic drugs (AEDs) can be discontinued in a subset of patients after 
surgery. We aimed to identify the factors related to successful AED withdrawal after 
surgery in pediatric patients with focal cortical dysplasia (FCD). 
Methods: The study included 134 patients who underwent resective surgery for 
FCD at Severance Hospital between 2003 and 2014. Age of seizure onset, epilepsy 
duration, and location and histopathological classification of the FCD were 
compared between patients who experienced seizure recurrence and those who 
did not. The interval between surgery and initiation of AED reduction was also 
compared. 
Results: In total, 134 patients were included. The median age at seizure onset was 1.0 
year (interquartile range [IQR], 0.3–5.0). The median follow­up duration was 6.0 years 
(IQR, 1.0–13.0). AED withdrawal was attempted in 89 (66%), and 61 (69%) patients 
remained seizure­free. Of 61 patients, 38 (62%) were successfully weaned off all 
AEDs. Seizures recurred in 28 (31%) patients. The mean duration between surgery and 
initiation of AED reduction did not significantly differ between the seizure recurrence 
(4.5 months, IQR, 2.7–8.7) and non­recurrence groups (1.9 months, IQR, 0.5–5.4) 
(P<0.006). Patients who had FCD type IIb (39% vs. 7%, P=0.004) were more likely to 
be in the non­recurrence group than in the recurrence group (P=0.031). 
Conclusion: Surgical resection offers patients with FCD an opportunity to completely 
discontinue their AEDs. Early AED discontinuation may be pursued in patients with 
FCD in cases of complete resection.
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Introduction
Epilepsy surgery remains the most effective treatment option for medically 
intractable epilepsy in children and adults1). The most common etiologies of the 
types of epilepsy observed in pediatric surgical candidates are focal cortical 
dysplasia (FCD), low-grade tumors, and hippocampal sclerosis2).
FCDs comprise a spectrum of focal developmental malforma tions 
characterized by disruption of the normal cytoarchitecture of the cerebral 
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cortex. They are highly associated with medically intractable 
epilepsy and recognized to be the most common in dication for 
pediatric epilepsy surgery3). 
Currently, there are no clear guidelines for the withdrawal of 
antiepileptic drugs (AEDs) after epilepsy surgery in patients with 
FCD, resulting in variations in the implementation of this with-
drawal among physicians. Many physicians continue to administer 
AEDs despite successful surgery, owing to concerns regarding 
seizure recurrence upon AED withdrawal, as well as the possi-
bility of failure to control seizures despite the readministration 
of AEDs4). 
A previous study showed that the tapering and discontinuation 
of AEDs may be considered in patients with epilepsy who have 
been seizure-free for 2 to 5 years5). However, recent studies sug-
gest that earlier AED withdrawal may be possible if the primary 
epileptic focus is completely resected6). Other recent reports have 
shown that the majority of US and Canadian epileptologists and 
neurologists prefer to wait for 6 months to 2 years before intro-
ducing any changes in medication7). Previous studies regarding 
AED discontinuation after epilepsy surgery examined the number 
of patients in whom the tapering and discontinuation of AEDs 
was successful as well as the rate of seizure relapse among these 
patients6,8-13). However, to the best of our knowledge, no study 
has analyzed this phenomenon exclusively in pediatric patients 
with FCD despite its differences in pathology, and disease course 
and prognosis from other epilepsy-related lesions.  
The purpose of the present study was to identify the rate of 
successful AED withdrawal after FCD resective surgery, as well 
as the predictors of seizure recurrence in pediatric patients with 
intractable epilepsy due to FCD. We also aimed to evaluate the 
appropriate timing for AED withdrawal and to determine which 




Patients who underwent epilepsy surgery at Severance Child-
ren’s Hospital between May 1, 2003 and September 1, 2014 were 
included in the present study. Patients were included if they met 
the following criteria: (1) pathologically confirmed FCD type I or 
II; (2) drug-resistant epilepsy, defined as uncontrolled seizures 
despite use of two appropriate AEDs; (3) seizure onset at the age 
of 18 years or younger; and (4) a minimum of 1 year of follow-
up. Patients who underwent lesionectomy, lobectomy, and multi-
lobar resections were included. Patients were excluded if they 
showed lesions consistent with FCD only on magnetic resonance 
imaging (MRI). Patients were also excluded if they had pathologi-
cally confirmed FCD type III, because the combined epilepto-
genic lesions were heterogeneous. Finally, patients who received 
corpus callosotomy or implantation of a vagal nerve stimulator 
were excluded. Diagnosis and classification of FCDs were made 
based on the 2011 International League Against Epilepsy classi-
fication3). The study was approved by the Institutional Review 
Board of Yonsei University Health Service, Severance Hospital 
(IRB approval number: No. 4-2017-0253). 
2. Procedures
To identify factors predictive of successful AED withdrawal, 
the following data were reviewed: age at seizure onset, sex, in-
terval between seizure onset and surgery, location of the surgery, 
histopathological classification of the resected tissue, postope-
rative electroencephalogram (EEG) abnormalities, and interval 
from surgery to the initiation of AED reduction. These factors 
were compared between patients who achieved freedom from 
seizures after surgery and those who did not. In order to identify 
factors that affect a physician’s decision to begin AED reduction, 
patients who underwent AED reduction were compared with 
those who did not. Subsequently, factors were compared bet-
ween patients who completed AED withdrawal and patients who 
experienced seizure recurrence in relation to AED reduction. 
Seizure outcome data based on the Engel criteria were col-
lected at each visit14). Routine postsurgical follow-up included 
outpatient visits at 3 months, 6 months, and 1 year. After 1 year, 
regular follow-up was performed every 6 to 12 months for pati-
ents who achieved seizure freedom. Seizure freedom was defined 
as absence of clinical seizures and auras after surgery until the 
last follow-up. Seizure recurrence was defined as reappearance 
of a clinical seizure after the initiation of AED in patients who 
achieved seizure freedom after surgery.  
Postoperative EEG abnormalities were assessed using 30- 
minute (routine) EEG recordings and ambulatory 4-hour EEG 
recordings. From the EEG recordings, background activity and 
epileptiform discharges including sharp waves, spikes, and par-
oxysmal fast activities were reviewed. The 10-20 system of elec-
trode placement was used. The EEG data were analyzed using 
TWin EEG software (Natus/Grass Technologies Ltd., Warwick, 
RI, USA).  
3. Statistical analysis
For comparisons between each group, chi-squared analysis, 
Fisher’s exact test, and Student's t-test were used to analyze nu-
merical variables. For the univariate analysis of FCD types, a stan-
dard forward stepwise Kaplan-Meier analysis was performed. 
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Data were obtained from electronic medical records. P values 
<0.05 were regarded as statistically significant. The data storage 
and statistical analyses were performed with SPSS software (ver-
sion 22.0; IBM Corp., Armonk, NY, USA). Values were expressed 
as number (%), mean±standard deviation (SD), or median (inter-
quartile range [IQR]). 
 
Results
In total, 134 patients with FCD underwent epilepsy surgery. 
Median age at seizure onset was 1.0 (IQR, 0.3-5.0) years. The 
patients included 80 boys and 54 girls. The median age of patients 
who underwent surgery was 7.0 (IQR, 3.0-12.0) years. Of the 134 
patients, 52 had FCD type I, 57 had FCD type IIa, and 25 had 
FCD type IIb. The median follow-up duration was 6.0 years (IQR, 
1.0-13.0). The median number of AEDs used before surgery was 
3.0 (IQR, 1.0-5.0) (Table 1).
Among the 134 patients, 106 (79%) patients initially achieved 
seizure freedom, and AED reduction was attempted in 89 (66%) 
after a median duration of 3.5 months following epilepsy surgery. 
Of these 89 patients, 61 (69%) maintained a seizure-free state. In 
the seizure-free group, 38 (62%) patients were successfully 
tapered off all AEDs, and 23 (38%) patients maintained seizure 
freedom with lower doses of AEDs. Seizure recurrence was ob-
served in 28 (31%) of the 89 patients in whom AED reduction was 
attempted. In the seizure recurrence group, seizure control or 
seizure reduction was regained with readjustment of AEDs in 24 
patients, while 4 patients experienced persistence or exacerba-
tion of seizures (Fig. 1).
Reduction of AEDs was more likely to be attempted postopera-
tively in patients with FCD type IIb (24% vs. 9%, P=0.039). Other 
factors including age at seizure onset, age at surgery, and location 
of the lesions were not related to attempts to reduce AEDs (Table 
2). 
To identify factors that predicted seizure recurrence, patients 
who were successfully weaned off all AEDs were compared with 
those who experienced seizure recurrence after AED reduction 
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Fig 1. Study population.
Table 1. Baseline Characteristics 
Total N of patients 134
Female   54 
Age at epilepsy onset (years) 1.0 (0.3–5.0)
Interval between seizure onset and surgery (years) 4.0 (1.7–7.6)
Age at surgery (years) 7.0 (3.0–12.0)
Side of the resected area (Left:Right) 80:54
N of AEDs  used before surgery 3.0 (1.0–5.0)
N of AEDs used after surgery 1.0 (0–6.0)
Interval between surgery and start of AED reduction (months) 3.8 (1.3–13.5)
Interval between start of AED reduction and last follow-up (years) 3.6 (1.0–12.4)
Lobar surgery location, N (%)
  Temporal 8 (6)
  Frontal 49 (37)
  Parietal 8 (6)
  Occipital 6 (4)
  Bilobar or multilobar 63 (47)
FCD type, N (%)
  FCD type I 52 (39)
  FCD type IIa 57 (43)
  FCD type IIb 25 (19)
N, number; AEDs, antiepileptic drugs; FCD, focal cortical dysplasia.
Values are described as number (%) or median (interquartile range). 




Did not start AED 
withdrawal (n=45)
P Value
Female 37 17 0.672
Age at epilepsy onset (years) 0.8 (0.3–5.0) 1.0 (0.2–4.5) 0.865
Interval between seizure onset and 
 surgery (years) 
3.2 (1.3–7.7) 5.0 (2.7–8.0) 0.158
Age at surgery (years) 7.0 (2.5–12.0) 7.0 (3.5–12.0) 0.599
Side of the resected area (Left:Right) 57:32 23:22 0.149
N of AEDs used before surgery 3.0 (2.0–4.0) 3.0 (2.0–4.0) 0.749
N of AEDs used after surgery 1.0 (0–2.0) 3.0 (2.0–4.0) 0.743
Surgery location, N (%)
  Temporal 6 (7) 2 (4) 0.596
  Frontal 37 (41) 12 (27) 0.091
  Parietal 5 (6) 3 (7) 0.809
  Occipital 4 (5) 2 (4) 0.989
  Bilobar or multilobar 37 (42) 26 (58) 0.076
FCD  type, N (%)
  FCD type I 35 (39) 17 (38) 0.833
  FCD type IIa 33 (37) 24 (53) 0.072
  FCD type IIb 21 (24) 4 (9) 0.039
AED, antiepileptic drugs; N, number; FCD, focal cortical dysplasia. 
Values are described as number (%) or median (interquartile range).
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(Table 3). Younger age at epilepsy onset (1.0 [0.3-5.0] vs. 1.1 
[0.3-3.8] years, P<0.001), shorter duration of epilepsy (1.9 [0.5-
5.4] vs. 4.5 [2.7-8.7] years, P=0.006), and lower number of pre-
operative AEDs (3.0 [2.0-3.3] vs. 4.0 [3.0-4.0], P<0.001) were 
found in patients who were successfully weaned off all AEDs 
compared to patients who experienced seizure recurrence. Pati-
ents were more likely to experience seizure recurrence if they 
underwent multilobar resection (54% vs. 29%, P=0.043) or had 
FCD type I (24% vs. 57%, P=0.010), while patients were more 
likely to remain in a seizure-free state after AED reduction if 
they had FCD type IIb (39% vs.7%, P=0.004). Interestingly, the 
interval between epilepsy surgery and the AED reduction trial 
was shorter in patients who maintained a seizure-free state than 
in patients who experienced seizure recurrence (1.6 [0.9-12.5] 
vs. 4.1 [2.8-6.0] years, P<0.001). 
AED reduction was started <3 months postoperatively for 39 
of 89 patients. Seizure recurrence occurred in 26% of these pa-
tients. Moreover, the AED was tapered between 3 and 6 months 
in 23 patients, between 6 and 12 months in 7 patients, between 
12 and 24 months in 13 patients, and after 24 months in 7 patients. 
The group that underwent early AED tapering (<3 months post-
operatively) had a low seizure recurrence rate (26%, P=0.296) 
while patients who underwent later AED tapering (≥24 months 
postoperatively) had a high seizure recurrence rate (57%, P= 
0.127). Early AED tapering was not associated with a higher inci-
dence of seizure recurrence.
Background activity and epileptiform discharges on postope-
rative follow-up EEGs were also reviewed. Patients who did not 
show interictal epileptiform discharges (IEDs) were more likely 
to remain in a seizure-free state following tapering off of AEDs 
(19/26, 73%) than the patients who showed IEDs (42/63, 67%, P= 
0.031). We did not find a significant relationship between pre-
sence of IEDs and timing of AED withdrawal (2.8 vs. 3.1 months, 
P<0.001).
The rate of seizure-free survival over time following surgery 
was analyzed according to FCD subtype using Kaplan-Meier 
survival curves. Patients with FCD type IIb were more likely to 
remain seizure-free after AED reduction (31%, P=0.013) (Fig. 2), 
and patients who underwent multilobar resection were more 
likely to experience seizure recurrence after AED reduction (54 
%, P=0.043) (Table 3). Age, number of AEDs taken before sur-
gery, frequency of seizures before attempting AED tapering, and 
brain MRI findings did not affect seizure recurrence after AED 
withdrawal. 
Discussion
After surgery, patients with FCD were more likely to complete 
AED discontinuation if FCD type was IIb, duration of epilepsy 
was short, and number of preoperatively used AEDs was small. 
Delayed start of AED reduction was not associated with suc-
cessful AED discontinuation.    






before or after AED 
withdrawal (n=28)
P Value
Female 17 11 0.802
Age at epilepsy onset (years) 1.0 (0.3–5.0) 1.1 (0.3–3.8) <0.001
Interval between seizure onset and 
 surgery (years)
1.9 (0.5–5.4) 4.5 (2.7–8.7) 0.006
Age at surgery (years) 6.5 (2.0–9.8) 8.5 (3.5–12.0) 0.200
Side of the resected area (Left:Right) 26:12 22:6 0.413
N of AEDs used before surgery 3.0 (2.0-3.3) 4.0 (3.0–4.0) <0.001
Surgery location, N (%)
  Temporal 3 (8) 1 (4) 0.631
  Frontal 19 (50) 9 (32) 0.208
  Parietal 3 (8) 2 (7) 1.000
  Occipital 2 (5) 1 (4) 1.000
  Bilobar or multilobar 11 (29) 15 (54) 0.043
FCD type, N (%)
  FCD type I 9 (24) 16 (57) 0.010
  FCD type IIa 14 (37) 10 (36) 0.925
  FCD type IIb 15 (39) 2 (7) 0.004
Interval between surgery and start of 
 AED reduction (months) 
1.6 (0.9–12.5) 4.1 (2.8–6.0) <0.001
AED, antiepileptic drugs; N, number; FCD, focal cortical dysplasia. 
Values are described as number (%) or median (interquartile range).
Fig. 2. Kaplan-meier survival vurves for the rate of seizure free patients for 
each focal cortical dysplasia subtype.
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Previous studies analyzed discontinuation of AEDs after sur-
gery in a heterogeneous group of patients with epilepsy. The 
relapse rates observed in these previous studies were similar to 
those seen in the present study, ranging between 12 and 44%12-
13,15-17).  Successful AED reduction could be achieved in patients 
regardless of the timing of this reduction18). Our study suggests 
that AED withdrawal following surgery in patients with FCD can 
be performed in a similar manner to that in patients with other 
epileptogenic regions. To the best of our knowledge, this study 
is the first to analyze AED withdrawal rates only in cases of FCD. 
AED reduction was more likely to be attempted in patients who 
had frontal lobe FCDs, and type IIb FCDs. Complete AED discon-
tinuation could be achieved more frequently in patients with type 
IIb FCDs. A previous study suggested more successful AED dis-
continuation in patients with temporal lesions than in those with 
extratemporal lesions, but we did not observe this trend in our 
study19). Another study also failed to find a similar relationship 
between FCD location and successful AED discontinuation6).
In the present study, slow withdrawal of AEDs was not asso-
ciated with successful AED reduction and seizure freedom. The 
mean duration between surgery and initiation of AED reduction 
did not significantly differ between the seizure recurrence and 
seizure-free groups. In contrast to the findings of this study, 
how ever, the results of a previous study showed that delayed 
timing of AED reduction increased successful AED withdrawal 
and seizure outcomes6). However, our results were concordant 
with the findings of a recent study that analyzed patients with 
epilepsy in general18). 
Postoperative EEGs were obtained to screen for background 
activity and the presence of epileptiform discharges in all patients 
in the present study. The absence of epileptiform discharges on 
the EEG was significantly associated with successful AED re-
duction (P=0.031). Thus, the electrophysiologic variables tested 
proved to be a significant predictor of seizure recurrence in our 
patients. However, previous reports have claimed that there are 
no significant differences in the rate of seizure recurrence bet-
ween patients with and without epileptic spikes on the post-
operative EEG9,11). 
In previous studies, factors associated with successful AED 
withdrawal were age at seizure onset, duration of epilepsy, brain 
MRI findings, postoperative EEG results, timing of AED tapering, 
and location of pathology7,9,20,21). However, the factors that showed 
a significant effect differed among studies. In some studies, suc-
cessful discontinuation was more common among younger pati-
ents and those with a shorter duration of epilepsy22).  A previous 
study reported that a longer duration of epilepsy prior to surgery, 
abnormal postoperative EEG findings, and early postoperative 
seizures predispose to seizure recurrence10). However, these 
findings were not statistically significant in the present study.
We acknowledge the following limitations of our study. Selec-
tion bias may have influenced the study population for AED 
withdrawal because our epilepsy center is a referral center for 
patients with severe drug-resistant epilepsy. The data may not 
be representative for other more benign conditions. In addition, 
all cases of seizures after surgery were considered a recurrence. 
This may have resulted in an underestimation of seizure freedom, 
as fever-triggered or acute postoperative seizures may also have 
been counted. 
Many children who undergo FCD resective surgery can be 
suc cessfully withdrawn from AEDs. Early drug tapering was not 
associated with a higher rate of seizure recurrence in the present 
study. Patients with FCD type IIb were more likely to remain sei-
zure-free following AED reduction. In conclusion, if the post-
operative pathology is FCD type IIb and no epileptic discharge 
is detected on the follow-up EEG, it is preferable to consider early 
AED tapering. Early AED tapering may be considered if the initial 
EEG obtained within 6 months of the surgery shows no definite 
epileptiform discharges. It is important to confirm these findings 
in a prospective, large-scale study. 
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요약
목적: 본 연구는 소아 국소 겉질 형성이상 환자에서 뇌전증 수술 
후 항경련제 복용 중단 성공과 관련된 요인들을 확인하고자 한다. 
방법: 2003 년부터 2014 년 까지 세브란스 병원에서 국소 겉질 형
성이상으로 수술적 제거술을 시행 받은 134명의 환자를 대상으로 후
향적 의무기록 분석을 시행하였다. 항경련제 중단 과정에서 경련 재발
을 경험한 환자군과 그렇지 않은 환자들의 성별, 뇌전증 발병 연령, 뇌
전증 유병 기간, 국소 겉질 형성이상의 위치 및 조직병리학적 분류, 수
술 후 항경련제 중단까지 걸린 시간 등을 분석하였다. 
결과: 뇌전증 발병 평균 연령은 1.0 (IQR, 0.3-5.0)년이었다. 평균 추
적 관찰 기간은 6.0 (IQR, 1.0-13.0)년 이었으며 총 134명 중 89명(66 
%)에서 항경련제 중단을 시작하였고 중단 후 28명(31%)에서 경련이 
재발하였으며, 경련 재발 없이 지속된 경우는 61명(69%)이었다. 이 61
명의 환자 중 38명(62%)이 모든 항경련제를 성공적으로 중단할 수 있
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었다. 수술 후 항경련제 중단을 시작하기까지 걸린 기간은 3.5 (IQR, 
0-90.1)개월이었고, 경련 재발 집단과 재발하지 않은 집단간에 의미 있
는 차이는 없었다. 국소 겉질 형성이상 조직학적 분류 IIb 일때 항경련
제 중단 후 경련 재발이 없을 가능성이 더 높았고(P=0.004), 뇌파 검
사에서 경련파가 보이지 않을 때 경련 재발 가능성이 더 적게 나타났
다(P=0.031).
결론: 국소 겉질 형성이상의 조직병리학적 분류와 뇌파 이상 소견
을 통해 수술 후 성공적인 항경련제 중단 여부를 예측할 수 있다. 수
술 후 항경련제 중단을 시작하는 시점이 빨라도 경련 재발률이 높아
지지 않으므로, 수술 후 적극적으로 항경련제 중단을 고려 및 시작하
는 것이 의미 있다. 
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